Lionsgate director gets 13,405-share stock grant

Lionsgate Studios Corp. director John D. Harkey Jr. received equity awards and fee shares, adding to his stock and restricted share unit holdings.

Rhea-AI Filing Summary

Lionsgate Studios Corp. (symbol: LION) is the issuer of record for a Form 4 filing submitted to the SEC. HARKEY JOHN D JR reported acquisition or exercise transactions in this Form 4 filing.

Lionsgate Studios Corp. (LION) reports that director John D. Harkey Jr. received equity compensation on September 15, 2026. He was granted 13,405 Common Shares at no cost as an annual director equity award and 5,809 Common Shares as director fees valued at $11.19 per share, both held directly. The company also notes he holds restricted share units covering 20,107 shares scheduled to vest on November 28, 2026 and 13,405 shares scheduled to vest on September 15, 2027, each payable in an equal number of common shares. No Rule 10b5-1 trading plan is indicated.

Insider Trade Summary

Grant/Award: 19,214 shares

Grant/Award 2 txns

Insider HARKEY JOHN D JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1, F2	13,405	$0.00	$0.00
Grant/Award	Common Shares F3, F2	5,809	$11.19	$65K

Holdings After Transaction: Common Shares — 227,402 shares (Direct)

Footnotes (3)

1. F1. Annual director equity award.
2. F2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
3. F3. Director fees paid in common shares.

Key Figures

Annual director equity award shares: 13,405 shares Director fee shares: 5,809 shares RSUs vesting November 28, 2026: 20,107 restricted share units +2 more

5 metrics

Annual director equity award shares 13,405 shares Common Shares granted to John D. Harkey Jr. on September 15, 2026 at $0.00 per share

Director fee shares 5,809 shares Common Shares paid as director fees on September 15, 2026 at $11.19 per share

RSUs vesting November 28, 2026 20,107 restricted share units Payable in an equal number of LION common shares upon vesting

RSUs vesting September 15, 2027 13,405 restricted share units Payable in an equal number of LION common shares upon vesting

Rule 10b5-1 plan status No Rule 10b5-1 plan reported Document-level 10b5-1 checkbox is not affirmatively marked for these transactions

Key Terms

restricted share units, annual director equity award, director fees paid in common shares

3 terms

restricted share units financial

"Amount includes the following restricted share units granted by the Issuer"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

annual director equity award financial

"Annual director equity award."

director fees paid in common shares financial

"Director fees paid in common shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Lionsgate Studios Corp. (LION) report for John D. Harkey Jr.?

On September 15, 2026, director John D. Harkey Jr. received 13,405 Common Shares as an annual director equity award and 5,809 Common Shares as director fees, both recorded as acquisitions of Common Shares held directly.

At what prices were the LION shares granted to John D. Harkey Jr.?

The annual director equity award of 13,405 shares was granted at a reported price of $0.00 per share, while the director fee award of 5,809 shares was valued at $11.19 per share.

What restricted share units does John D. Harkey Jr. hold in Lionsgate Studios Corp. (LION)?

He holds restricted share units covering 20,107 shares scheduled to vest on November 28, 2026 and 13,405 shares scheduled to vest on September 15, 2027, each payable in an equal number of LION common shares upon vesting.

Were the LION insider equity awards to John D. Harkey Jr. made under a Rule 10b5-1 plan?

No. The filing indicates the Rule 10b5-1 plan checkbox is not marked affirmatively, and no footnote states that the September 15, 2026 equity awards or fee shares were made under a Rule 10b5-1 trading plan.

Does the Form 4 disclose John D. Harkey Jr.’s total LION shareholdings after these transactions?

No total shareholding figure after the transactions is reported in the data, but the Form 4 does state the 13,405-share equity award, the 5,809-share fee award, and the two tranches of restricted share units with their vesting dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:52 PM Accepted by SEC EDGAR 09/17/2026 - 04:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HARKEY JOHN D JR

(Last) (First) (Middle)

LIONSGATE

2700 COLORADO AVENUE

(Street)

SANTA MONICA CALIFORNIA 90404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/15/2026		A		13,405(1)	A	$0	221,593(2)	D
Common Shares	09/15/2026		A		5,809(3)	A	$11.19	227,402(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual director equity award.

2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.

3. Director fees paid in common shares.

Remarks:

	John D. Harkey, Jr. (By Adrian Kuzycz by Power of Attorney)	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)